Chadds Ford, PA, United States of America

Patrick Yuk Sun Lam

This inventor holds 2 USPTO granted patents. Top assignee: Bristol-Myers Squibb Pharma Company. Active years: 2002-2005.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Patrick Yuk Sun Lam. Retrieved from https://idiyas.com/inventor/patrick-yuk-sun-lam-pe7pfltf

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 9.0

ph-index = 1

Forward Citations = 20(Granted Patents)


Company Filing History:


Years Active: 2002-2005

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovator Spotlight: Patrick Yuk Sun Lam

Introduction: Meet the talented inventor, Patrick Yuk Sun Lam, based in Chadds Ford, PA, US. With an impressive contribution to the field of pharmaceuticals, Patrick has obtained 2 patents in his career.

Latest Patents: Patrick's latest patents revolve around "Nitrogen containing heterobicycles as factor Xa inhibitors." These patents describe nitrogen-containing heterobicyclics and their derivatives, or salt forms, showcasing their utility as factor Xa inhibitors.

Career Highlights: Patrick Yuk Sun Lam is affiliated with Bristol-Myers Squibb Pharma Company, where he demonstrates his expertise in developing innovative pharmaceutical solutions. His dedication to research and development has led to the successful filing of multiple patents in the cutting-edge field of pharmaceuticals.

Collaborations: Within his professional journey, Patrick has collaborated with esteemed colleagues such as John Matthew Fevig and Joseph Cacciola. Together, they have worked towards advancing pharmaceutical research and contributing to the development of novel treatments.

Conclusion: Patrick Yuk Sun Lam's groundbreaking work in the realm of pharmaceutical inventions exemplifies his passion for innovation and commitment to advancing scientific discoveries. With a bright future ahead, Patrick continues to make significant contributions to the field, shaping the landscape of pharmaceutical research and development.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…